跳至主要内容
临床试验/NCT00667134
NCT00667134已完成不适用

Stimulatory Autoantibodies to the PDGFR and Phosphorylation of the PDGFR in Patients With Systemic Sclerosis

University of Michigan1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2008年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
26
试验地点
1
主要终点
Stimulatory autoantibodies to the PDGF receptor

研究概览

简要总结

This study is to determine if subjects with .systemic sclerosis have stimulatory autoantibodies to the PDGF receptor and to confirm activation (phosphorylation) of the PDGF receptor in skin sites with varying degrees of skin thickening

详细描述

Pilot study to assess whether patients with systemic sclerosis have stimulatory autoantibodies to the PDGF receptor and to confirm activation (phosphorylation) of the PDGF receptor in skin sites with varying degrees of skin thickening

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Fulfill the American College of Rheumatology criteria for systemic sclerosis or:
  • Have no diseases that result in primary fibrosis of an organ system, including the skin and do not have an autoimmune disease

排除标准

  • If the subject has systemic sclerosis resulting from an environmental exposure
  • If the subject has an autoimmune disease excluding scleroderma
  • If the subject has an active infection (including, but not limited to hepatitis B, hepatitis C and HIV)
  • If the subject has been treated with cyclophosphamide in the past 8 weeks.
  • If the subject is prone to bleeding because they are on medications that thin the blood or have a low platelet count.

结局指标

主要结局

Stimulatory autoantibodies to the PDGF receptor

时间窗: 1 year

次要结局

  • Phosphorylation of the PDGF receptor in patients with systemic sclerosis(One year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kristine Phillips

clinical assistant professor

University of Michigan

研究点 (1)

Loading locations...

相似试验